Although the situation varies widely by region and by country, current national funding covers only a fraction of what is needed for the implementation of malaria control programs, especially in high burden countries. This is particularly true in Africa, where government budgets represent only 18% on average of total malaria funding.
[47] In 2003, African leaders affirmed in the Maputo Declaration their commitment to increase financial support for the health sector to 15% of total government expenditure. Today, however, 90% of African countries remain below the 15% threshold.
[48] Even if countries were to achieve the 15% target, their expenditures on key malaria interventions would still be substantially less than the estimated need. As shown in Figure I.4, government expenditures on health per capita are the lowest in regions with the highest malaria burden.
Figure I.4: Government expenditure on health in malaria-endemic regions
Note: Government expenditure on health per capita as regional weighted average; % of government expenditure on health as arithmetical average, 15% target agreed by African countries in Maputo Declaration (July 2003)
Source: Analysis based on WHO Health Statistics 2008; 2005 data
According to data from WHO and the main donor organizations, the share of government budget spent on malaria is substantially higher in Asia-Pacific than in Africa and represents the largest source of malaria funding in the Americas and in the Middle East and Eurasia. Detailed regional analyses of funding for malaria are presented in
Part III: Regional Strategies.
Money spent on malaria in 2007 amounted to an estimated total of ~US$ 1.5 billion (see Figure I.5). One fifth of these funds came from household purchases of malaria products (such as anti-malarial drugs or long-lasting insecticidal nets) principally through the private sector. Approximately 34% of funds came from national government expenditures dedicated to malaria, and the remaining funding came from international donors, which disbursed an estimated US$ 701 million. The Global Fund contributed to half of the disbursements from international donors.
[49]
Figure I.5: Current sources of funds spent on malaria
a) Regional funding estimates not available for private household spend and other USAID. Therefore, summing regional funds presented in Part III – Regional Strategies only adds up to approx. $1.1 billion, see appendix 3 for methodology
Source: World Malaria Report 2008. Geneva, World Health Organization, 2008 (Government, UN Agencies, Bilaterals, EU); the Global Fund website; PMI operational plans; USAID website; World Bank Booster Program (see appendix on methodology); 2007 data
As Figure I.6 illustrates, unprecedented amounts of money have poured into malaria control since 2004. Disbursements from international donors increased threefold from 2004 to 2007. Commitments for coming years are promising. 2008 disbursements are estimated to be ~US$ 1.1 billion, (more than four times 2004 amount) thanks to expected payouts of previous Global Fund rounds, increased scope of the U.S. President’s Malaria Initiative (PMI) (from 10 countries in 2007 to 15 countries supported in 2008) and the disbursements of money committed in Phase I of the World Bank Booster Program (~67% of Phase I commitments are expected to be disbursed by the end of 2008).
Figure I.6: Evolution of international funding disbursements for malaria
Source: World Malaria Report 2008. Geneva, World Health Organization, 2008 (Government, UN Agencies, Bilaterals, EU); GFATM website; PMI operational plans; USAID website; World Bank Booster Program (see appendix on methodology)
Both the Global Fund (US$ 9.7 billion for 2008-2010)
[50] and the World Bank (US$ 41.6 billion for the International Development Association’s 15th replenishment)
[51] have been highly successful in advocating for replenishments. While G8 donor countries are still far from reaching the aid pledges made to Africa in 2005 in Gleneagles, individual governments have increased their pledged funds and other donations for malaria. In April 2008, Prime Minister Gordon Brown announced the United Kingdom's government's pledge to donate 20 million bed nets. In July 2008, the President of the United States signed a reauthorization act that could increase US malaria funding to US$ 5 billion over the next five years.
[52] The World Bank is preparing Phase II of its Booster program with an aspirational lending target of at least ~ US$ 1.2 billion for sub-Saharan Africa. In addition, the World Bank's Board of Executive Directors has just approved over US$ 500 million for a project to support India’s efforts against malaria and other diseases, for which the amount for malaria could reach US$ 200 million,
[53] making it the largest single disease control investment in the history of the World Bank.
Increased Funding for Malaria Research and Development
Figure I.7 shows the steady increase in funding for malaria research and development over the past five years. In 2007, funding for malaria research and development is estimated at ~US$ 422 million. The two major donors (United States’ National Institutes of Health and the Bill and Melinda Gates Foundation) account for ~40% of estimated current funding for R&D. More than 60% of funds are directed to drugs and vaccines.
Figure I.7: Evolution of spending on malaria research and development
Note: Estimated $165M in funding from “other” donors based on Malaria R&D Alliance estimate for 2004; assumes all BMGF malaria funding is for R&D
Source: Bill ∓ Melinda Gates Foundation; National Institutes of Health website; Malaria R&D Alliance (2005)
